Overview
Opdivo Qvantig is approved by the U.S. Food and Drug Administration (FDA) as part of a treatment regimen for non-small cell lung cancer (NSCLC) in certain scenarios. These include use in combination with…
Overview
Opdivo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic non-small cell lung cancer. Opdivo is often prescribed with ipilimumab (Yervoy). Opdivo is also known by… read more